CareDx (CDNA) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CareDx, Inc. Reports First Quarter 2015 Financial Results
May 12, 2015 4:05 PM EDTQuarterly Revenue Growth of 22% Year Over Year
Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial
BRISBANE, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three months ended March 31, 2015.
2015 highlights year to date:
Total revenues for the first quarter... MoreCareDx, Inc. Reports First Quarter 2015 Financial Results
May 12, 2015 4:05 PM EDTQuarterly Revenue Growth of 22% Year Over Year
Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial
BRISBANE, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three months ended March 31, 2015.
2015 highlights year to date:
Total revenues for the first quarter... More